Literature DB >> 17892364

Oncogene and tumor-suppressor gene products as serum biomarkers in occupational-derived lung cancer.

Simone Helmig1, Joachim Schneider.   

Abstract

Since lung cancer is the most frequent occupational cancer and one of the leading causes of cancer mortality in the world, it is one of the biggest challenges for research. In the literature, there are inconsistent results regarding the utility of the serum biomarkers p53, anti-p53 antibodies, EGF receptor or Ras. Based on the published results, routine use of these biomarkers for detection of occupationally derived lung carcinomas is not currently recommended. In this review, we summarize the literature and discuss the relevance of these oncogene and tumor-suppressor gene products as serum biomarkers in occupational-derived lung cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17892364     DOI: 10.1586/14737159.7.5.555

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN: 1473-7159            Impact factor:   5.225


  4 in total

Review 1.  Role of DMP1 and its future in lung cancer diagnostics.

Authors:  Takayuki Sugiyama; Donna P Frazier; Pankaj Taneja; Rachel L Morgan; Mark C Willingham; Kazushi Inoue
Journal:  Expert Rev Mol Diagn       Date:  2008-07       Impact factor: 5.225

2.  Investigation of anti-cancer mechanisms by comparative analysis of naked mole rat and rat.

Authors:  Zhiyuan Yang; Yan Zhang; Luonan Chen
Journal:  BMC Syst Biol       Date:  2013-10-14

3.  Interferon induced transmembrane protein 3 regulates the growth and invasion of human lung adenocarcinoma.

Authors:  Dong Zhang; Huimin Wang; Huijie He; Haiying Niu; Yu Li
Journal:  Thorac Cancer       Date:  2017-05-23       Impact factor: 3.500

4.  Gene promoter methylation assayed in exhaled breath, with differences in smokers and lung cancer patients.

Authors:  Weiguo Han; Tao Wang; Andrew A Reilly; Steven M Keller; Simon D Spivack
Journal:  Respir Res       Date:  2009-09-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.